Journal Information

Statistics

Follow this link to access the full text of the article

A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM): INITIAL SAFETY RESULTS FOR MAGNETISMM-3
AM Lesokhina, B Arnulfb, R Niesvizkyc, M Mohtyd, NJ Bahlise, MH Tomassonf, P Rodrguez-Oterog, H Quachh, NS Rajei, S Iidaj, M Raabk, A Cziberel, S Sullivanl, E Leipl, A Viqueiram, V Blunkn, X Leleuo,k
a Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, United States
b Hôpital Saint-Louis, Paris, France
c Weill Cornell Medical College - New York Presbyterian Hospital, New York, United States
d Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
e Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada
f Holden Comprehensive Cancer Center, University of Iowa, Iowa City, United States
g Clinica Universidad de Navarra, Madrid, Spain
h University of Melbourne, Melbourne
i Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, United States
j Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
k Heidelberg Myeloma Center, Department of Hematology/Oncology, Heidelberg University Hospital, Heidelberg, Germany
l Pfizer Inc, Cambridge, United States
m Pfizer SLU, Madrid, Spain
n Pfizer Inc, São Paulo, Brazil
o Centre Hospitalier Universitaire de Poitiers, Poitiers, France
Ver más
Read
1225
Times
was read the article
502
Total PDF
723
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 May 31 12 43
2025 April 32 13 45
2025 March 51 14 65
2025 February 43 18 61
2025 January 34 22 56
2024 December 28 10 38
2024 November 46 17 63
2024 October 37 20 57
2024 September 45 16 61
2024 August 40 18 58
2024 July 40 29 69
2024 June 33 30 63
2024 May 36 22 58
2024 April 32 22 54
2024 March 20 20 40
2024 February 22 20 42
2024 January 14 9 23
2023 December 13 22 35
2023 November 23 19 42
2023 October 16 32 48
2023 September 7 21 28
2023 August 17 18 35
2023 July 7 3 10
2023 June 10 12 22
2023 May 10 7 17
2023 April 7 5 12
2023 March 4 7 11
2023 February 6 9 15
2023 January 5 7 12
2022 December 7 15 22
2022 November 4 8 12
2022 October 3 5 8
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy